Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Expert Opinion on Therapeutic Patents|November 9, 2010
Novel N-methyl-D-aspartate receptor antagonists: a review of compounds patented since 2006Manuel Koller, Stephan UrwylerACS Applied Materials & Interfaces|November 15, 2014
Pressure-Sensitive Adhesives under the Influence of Relative Humidity: Inner Structure and Failure MechanismsMarkus Schindler, Manuel Koller, Peter Müller-BuschbaumEuropean Journal of Pharmacology|April 17, 2010
Comparative pharmacology of the human NMDA-receptor subtypes R1-2A, R1-2B, R1-2C and R1-2D using an inducible expression systemDominik Feuerbach, Erika Loetscher, Stephanie Neurdin, et al.Journal of Medicinal Chemistry|August 1, 2009
Drug design, in vitro pharmacology, and structure-activity relationships of 3-acylamino-2-aminopropionic acid derivatives, a novel class of partial agonists at the glycine site on the N-methyl-D-aspartate (NMDA) receptor complexStephan Urwyler, Philipp Floersheim, Bernard L Roy, et al.Science (New York, N.Y.)|October 14, 2017
A cryofuge for cold-collision experiments with slow polar moleculesXing Wu, Thomas Gantner, Manuel Koller, et al.The Journal of Pharmacology and Experimental Therapeutics|September 5, 2003
N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor functionStephan Urwyler, Mario F Pozza, Kurt Lingenhoehl, et al.Bioorganic & Medicinal Chemistry Letters|September 12, 2012
Discovery of 1H-pyrrolo[2,3-c]pyridine-7-carboxamides as novel, allosteric mGluR5 antagonistsManuel Koller, David A Carcache, David Orain, et al.Bioorganic & Medicinal Chemistry Letters|May 3, 2011
Quinazolinedione sulfonamides: a novel class of competitive AMPA receptor antagonists with oral activityManuel Koller, Kurt Lingenhoehl, Markus Schmutz, et al.Chemmedchem|November 19, 2016
Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor AntagonistDavid Orain, Engin Tasdelen, Samuel Haessig, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 16, 2015
Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited SettingsManuel Koller, Geoffrey Fatti, Benjamin H Chi, et al.Pageof 2